CRISPR Therapeutics Announces Promotion of Samarth Kulkarni, Ph.D. to Chief Executive Officer – GlobeNewswire (press release)
Endpoints News |
CRISPR Therapeutics Announces Promotion of Samarth Kulkarni, Ph.D. to Chief Executive Officer
GlobeNewswire (press release) ZUG, Switzerland and CAMBRIDGE, Mass., Oct. 02, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, announced today … Sam Kulkarni takes the helm at CRISPR Therapeutics as founding CEO steps down CRISPR Therapeutics AG (NASDAQ:CRSP) Experiences Lighter than Usual Trading Volume Somewhat Favorable News Coverage Somewhat Unlikely to Impact CRISPR THERAPTC (CRSP) Share Price |
